ConductScience.org, home

Paper577380

Modification of the classification of the eye changes of Graves' disease.

Werner SC. Am J Ophthalmol, 1977. Cited by 196 papers, by iCite.

Cite this record

ConductScience Library. Modification of the classification of the eye changes of Graves' disease. Papers, record 577380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/577380

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modification of the classification of the eye changes of Graves' disease.
PubMed
Journal
Am J Ophthalmol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
196
iCite
Relative citation ratio, by iCite
7.74
iCite
Revised in PubMed
2022-03-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Werner SCS C

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Eye DiseasesMajor topic
Graves DiseaseMajor topic
Humans
Terminology as Topic

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00348413Thyroid Treatment TrialBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.

PMIDTitleJournalYearIn PapersSource
41649397Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease.J Clin Endocrinol Metab2026https://conductscience.org/library/papers/41649397PubMed
41297932Impacts of physical, metabolic, and immunological factors on the exophthalmometry values of a contemporary Japanese population with/without Graves' disease.Endocr J2026https://conductscience.org/library/papers/41297932PubMed
41059227Clinical profiling of TPOAb and TGAb in patients with thyrotrophin receptor antibody-negative thyroid eye disease: A single-center observational study in China.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41059227PubMed
40888942Pediatric graves' orbitopathy: a case series of 136 Chinese patients.Int Ophthalmol2025https://conductscience.org/library/papers/40888942PubMed
40764083
Association between initial lipid and lipoprotein levels, oxidative stress indicators and clinical efficacy of intravenous methylprednisolone in moderate-to-severe thyroid-associated ophthalmopathy: protocol for a real-world prospective cohort study.
BMJ Open2025https://conductscience.org/library/papers/40764083PubMed
38983053The association of race with thyroid eye disease presentation and outcomes.Front Ophthalmol (Lausanne)2023https://conductscience.org/library/papers/38983053PubMed
38804861The circulating IL-35+ regulatory B cells are associated with thyroid associated opthalmopathy.Immun Inflamm Dis2024https://conductscience.org/library/papers/38804861PubMed
38728262Single-cell BCR and transcriptome analysis reveals peripheral immune signatures in patients with thyroid-associated ophthalmopathy.Aging (Albany NY)2024https://conductscience.org/library/papers/38728262PubMed
37606076Circulating miR-146a predicts glucocorticoid response in thyroid eye disease.Eur Thyroid J2023https://conductscience.org/library/papers/37606076PubMed
37060084
Efficacy of selenium supplementation for mild-to-moderate Graves' ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial.
Trials2023https://conductscience.org/library/papers/37060084PubMed
36539754Analysis of macular blood flow changes in thyroid associated ophthalmopathy.BMC Ophthalmol2022https://conductscience.org/library/papers/36539754PubMed
36185985The Effect of Thyroid Eye Disease on Corneal Biomechanical Properties.Beyoglu Eye J2022https://conductscience.org/library/papers/36185985PubMed
35791115Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.Indian J Ophthalmol2022https://conductscience.org/library/papers/35791115PubMed
35551579Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy.Int Ophthalmol2022https://conductscience.org/library/papers/35551579PubMed
35309667RAPD as a clinical alert for early evidence of dysthyroid optic neuropathy.J Family Med Prim Care2022https://conductscience.org/library/papers/35309667PubMed
34637060Altered peripapillary vessel density and nerve fiber layer thickness in thyroid-associated ophthalmopathy using optical coherence tomography angiography.Int Ophthalmol2022https://conductscience.org/library/papers/34637060PubMed
33899194Graves' Orbitopathy: Report of 82 cases.Tunis Med2021https://conductscience.org/library/papers/33899194PubMed
33564472The Clinical Features of Graves' Orbitopathy with Elevated Intraocular Pressure.J Ophthalmol2021https://conductscience.org/library/papers/33564472PubMed
33374706Current Knowledge on Graves' Orbitopathy.J Clin Med2020https://conductscience.org/library/papers/33374706PubMed
32681301[Orbital decompression in Graves' orbitopathy-Experiences and results].Ophthalmologe2021https://conductscience.org/library/papers/32681301PubMed

See all 68 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/577380

GET https://conductscience.org/api/papers/v1/577380/cited_by?page=2